BSP - Biological Signal Processing
Noninvasive Diagnosis of Cardiac Disease
Company Overview
Snapshot
Founded in January 2000 by Amir Beker, BSP - Biological Signal Processing operates with 1–10 employees. The company specializes in noninvasive diagnosis and monitoring of ischemic heart disease, leveraging its patented high-frequency technology. A significant milestone for the company was its initial public offering on the TASE in May 2006.
Business overview
BSP - Biological Signal Processing develops products for the noninvasive diagnosis and monitoring of ischemic heart disease. The company's core technology is its patented high-frequency HyperQ line of products, which offers solutions for both stress and resting ECG tests. These products are designed to improve the diagnosis of coronary artery disease and detect acute coronary syndrome in emergency settings. BSP serves the healthcare industry, particularly clinics, hospitals, and healthcare providers, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices.
Strategic signal
In July 2018, BSP Medical participated in a medical delegation to India, indicating a strategic focus on international market expansion and engagement. This move suggests the company was actively exploring new opportunities for its noninvasive cardiac diagnostic technologies in emerging markets, aiming to broaden its commercial reach and validate its solutions on a global scale.
Log in to access full profile ›Company Intelligence Q&A
- When was BSP - Biological Signal Processing founded?
- BSP - Biological Signal Processing was founded in January 2000.
- What is the primary focus of BSP - Biological Signal Processing?
- BSP - Biological Signal Processing focuses on the noninvasive diagnosis and monitoring of ischemic heart disease using its patented high-frequency HyperQ technology.
- What was a key public market event for BSP - Biological Signal Processing?
- BSP - Biological Signal Processing completed an Initial Public Offering (IPO) on the TASE in May 2006.
- What was a notable international activity for BSP Medical?
- In July 2018, BSP Medical participated in a medical delegation to India, signaling efforts to expand its market presence internationally.
- What happened to BSP - Biological Signal Processing in May 2018?
- BSP - Biological Signal Processing was delisted from the TASE in May 2018.